Meeting Details

The 17th Annual General Meeting of Nephrocare Health Services Limited was held on Wednesday, August 12, 2026, at 2:30 PM IST through Video Conferencing/Other Audio-Visual Means facility. The deemed venue was the Registered Office of the Company at 5th Floor, D Block, iLabs Centre, Plot 18, Software Units Layout, Survey No. 64, Madhapur, Shaikpet, Hyderabad – 500081, Telangana, India.

Attendance

Directors Present:

  • Mr. Vikram Vuppala - Chairman and Managing Director and Chairman of the Risk Management Committee (Hyderabad)
  • Mr. Hemant Sultania - Independent Director and Chairman of the Audit Committee (Gurugram)
  • Mr. Om Prakash Manchanda - Independent Director & Chairman of Nomination and Remuneration Committee (Gurugram)
  • Mr. Gaurav Sharma - Nominee Director & Chairman of the Stakeholders Relationship Committee (Mumbai)
  • Mr. Vishal Vijay Gupta - Nominee Director (Bangalore)
  • Mr. Sunil Kumar Thakur - Nominee Director (Delhi)
  • Ms. Annette Kumlien - Independent Director (France)
  • Dr. Ajay Bakshi - Independent Director (New Delhi)

Other Attendees:

  • Mr. Kamal D Shah - Co-founder (Hyderabad)
  • Mr. Rohit Singh - Group CEO (Hyderabad)
  • Mr. Prashant Goenka – Group CFO (Hyderabad)
  • Mr. Kishore Kathri - Company Secretary & Head Legal (Hyderabad)
  • Mr. Amit Kumar Bajaj - Partner, BSR and Co, Chartered Accountants, Statutory Auditors (Hyderabad)
  • Mr. Vaibhav Dandawate, Partner - Makarand M. Joshi & Co., Secretarial Auditor (Mumbai)
  • Ms. Rashida Hatim Adenwala, Founder Partner R & A Associates, Company Secretaries - Scrutinizer (Hyderabad)

Quorum

A total of 74 Members attended the Meeting.

Proceedings Summary

Mr. Kishore Kathri, Company Secretary, welcomed members and briefed them about the meeting process. Statutory registers and documents were made available on the company website. The proxy facility was not applicable for this virtual meeting.

Mr. Vikram Vuppala chaired the meeting and directors introduced themselves. The Chairman confirmed the statutory auditor's report contained no qualifications, reservations, adverse remarks or disclaimers.

For Item Nos. 5 and 6 where Mr. Vikram Vuppala was interested, Mr. Om Prakash Manchanda, Independent Director, chaired the proceedings.

Resolutions Transacted

1. Ordinary Resolution: Adoption of Audited Standalone and Consolidated Financial Statements for financial year ended March 31, 2026 together with Auditors' Report and Board's Report

2. Ordinary Resolution: Re-appointment of Mr. Gaurav Sharma (DIN: 03311656) as Nominee Director (Non-Executive category), liable to retire by rotation

3. Special Resolution: Approval for NephroPlus Employee Stock Option Scheme, 2026

4. Special Resolution: Approval for grant of Employee Stock Options to employees of subsidiary, associate company incorporated in India or outside India, or holding company under NephroPlus Employee Stock Option Scheme – 2026

5. Special Resolution: Approval for clarificatory amendment to special resolution passed by shareholders regarding remuneration of Mr. Vikram Vuppala (DIN: 02847323), Chairman & Managing Director

6. Ordinary Resolution: Approval for Promote Incentive Arrangement pursuant to Promote Agreement dated July 25, 2025, entered by Mr. Vikram Vuppala with certain Shareholders

Voting and Results

Members were invited to exercise voting rights through e-voting facility during the meeting. Queries from speaker shareholders were addressed by management.

Ms. Rashida Hatim Adenwala was appointed as Scrutinizer to scrutinize votes cast through e-voting at AGM and remote e-voting. Mr. Kishore Kathri was authorized to receive the Scrutinizer's Consolidated Report, declare results, and submit to stock exchanges within prescribed timelines.

Subject to receipt of requisite votes, all resolutions were deemed passed on August 12, 2026. The e-voting facility remained open for 15 minutes after proceedings concluded.

Meeting Duration

The meeting concluded at 3:32 PM IST.